| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 0 | 1 | 0 |
| Gross Profit | -0 | 1 | 0 |
| Operating Income | -16 | -24 | -8 |
| Net Income | -14 | -25 | -9 |
| EBITDA | -16 | -24 | -8 |
| EPS Diluted | -0.24 | -0.38 | -0.08 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 11 | 11 | 7 |
| Total Current Assets | 11 | 18 | 8 |
| Total Assets | 11 | 18 | 8 |
| Total Current Liabilities | 1 | 5 | 7 |
| Total Liabilities | 2 | 6 | 12 |
| Total Equity | 9 | 13 | -3 |
| Total Debt | 1 | 1 | 5 |
| Net Debt | -10 | -10 | -2 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | -4 | -11 | -19 |
| Capital Expenditure | -0 | -0 | -0 |
| Free Cash Flow | -4 | -11 | -19 |
| Stock-Based Comp | 1 | 2 | 1 |
| Net Change in Cash | 5 | 1 | -4 |